Gapping up
In reaction to strong earnings/guidance: MY +4.8%.
M&A news: ITMN +36% (enters into a definitive merger agreement for Roche (RHHBY) to fully acquire InterMune at a price of $74.00 per share), THI +17% (Tim Hortons and Burger King (BKW) confirm talks regarding potential strategic transaction), BKW +16.5% (Tim Hortons and Burger King (BKW) confirm talks regarding potential strategic transaction), TLM +1% (reports indicate Iraq Kurdistan sale process is proceeding).
Select alt energy related names showing strength: BIOF +5.2%, CPST +2.4%, FCEL +1.9%, PLUG +1%.
Other news: DGLY +19.3% (Pres Obama reportedly to initiate an audit on police military equipment), PZG +11.1% (announces results of PEA for its 100%-owned San Miguel gold and silver project in Chihuahua State), ADXS +7.7% (Co and Merck (MRK) form collaboration to evaluate investigational combination of two novel immunotherapy candidates for advanced prostate cancer), AMPE+7% (issues letter to shareholders in regard to the STEP study and co's plans for the Ampion BLA), ANN +6.6% (Co responds to activist activity, reports over weekend urging to co to sell itself), DRL +4% (Puerto Rico Department of Justice and Treasury issued joint statement late Friday), AKS +2.8% (X peer, X upgraded at CS), EXAS +2.6% (announces Mayo Clinic as first healthcare system to offer Cologuard), TASR +2.5% (Pres Obama reportedly to initiate an audit on police military equipment), KING +2.1% (still checking), LRAD +2% (Pres Obama reportedly to initiate an audit on police military equipment), MSG +1.9% (JAT Capital Management discloses 6.73% active stake in 13D filing), ICPT +1.4% (may be related to ITMN takeover), LJPC +1.2% (Announces First Patient Enrolled in Clinical Trial of LJPC-501 in Hepatorenal Syndrome).
Analyst comments: XGTI +13.4% (initiated with a Buy at ROTH Capital), X +3.4% (upgraded to Outperform from Underperform at Credit Suisse), ELGX +3.1% (upgraded to Buy from Neutral at BTIG Research), AAVL +2.7% (initiated with a Buy at Jefferies), JCP +2.5% (may be attributed to positive JPMorgan comments), TNP +1.6% (initiated with a Outperform at Wells Fargo), CBOE +1.4% (upgraded to Outperform from Mkt Perform at Raymond James), WPX +1.3% (upgraded to Sector Outperform at Howard Weil)
In reaction to strong earnings/guidance: MY +4.8%.
M&A news: ITMN +36% (enters into a definitive merger agreement for Roche (RHHBY) to fully acquire InterMune at a price of $74.00 per share), THI +17% (Tim Hortons and Burger King (BKW) confirm talks regarding potential strategic transaction), BKW +16.5% (Tim Hortons and Burger King (BKW) confirm talks regarding potential strategic transaction), TLM +1% (reports indicate Iraq Kurdistan sale process is proceeding).
Select alt energy related names showing strength: BIOF +5.2%, CPST +2.4%, FCEL +1.9%, PLUG +1%.
Other news: DGLY +19.3% (Pres Obama reportedly to initiate an audit on police military equipment), PZG +11.1% (announces results of PEA for its 100%-owned San Miguel gold and silver project in Chihuahua State), ADXS +7.7% (Co and Merck (MRK) form collaboration to evaluate investigational combination of two novel immunotherapy candidates for advanced prostate cancer), AMPE+7% (issues letter to shareholders in regard to the STEP study and co's plans for the Ampion BLA), ANN +6.6% (Co responds to activist activity, reports over weekend urging to co to sell itself), DRL +4% (Puerto Rico Department of Justice and Treasury issued joint statement late Friday), AKS +2.8% (X peer, X upgraded at CS), EXAS +2.6% (announces Mayo Clinic as first healthcare system to offer Cologuard), TASR +2.5% (Pres Obama reportedly to initiate an audit on police military equipment), KING +2.1% (still checking), LRAD +2% (Pres Obama reportedly to initiate an audit on police military equipment), MSG +1.9% (JAT Capital Management discloses 6.73% active stake in 13D filing), ICPT +1.4% (may be related to ITMN takeover), LJPC +1.2% (Announces First Patient Enrolled in Clinical Trial of LJPC-501 in Hepatorenal Syndrome).
Analyst comments: XGTI +13.4% (initiated with a Buy at ROTH Capital), X +3.4% (upgraded to Outperform from Underperform at Credit Suisse), ELGX +3.1% (upgraded to Buy from Neutral at BTIG Research), AAVL +2.7% (initiated with a Buy at Jefferies), JCP +2.5% (may be attributed to positive JPMorgan comments), TNP +1.6% (initiated with a Outperform at Wells Fargo), CBOE +1.4% (upgraded to Outperform from Mkt Perform at Raymond James), WPX +1.3% (upgraded to Sector Outperform at Howard Weil)